Effects of methylphenidate on fatigue and depression: A randomized, double-blind, placebo-controlled trial

Journal of Pain and Symptom Management

Volumn 43, Issue 1, 2012, Pages 68-77

  Kerr, Christopher W ^a   Drake, Julie ^b   Milch, Robert A ^a   Brazeau, Daniel A ^b   Skretny, Judith A ^a   Brazeau, Gayle A ^b   Donnelly, James P ^a  

^a Center for Hospice and Palliative Care   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

depression; fatigue; hospice; Methylphenidate; placebo controlled

Indexed keywords

HEMOGLOBIN; METHYLPHENIDATE; PLACEBO;

ADULT; AGED; ANXIETY; APPETITE; ARTICLE; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EDMONTON SYMPTOM ASSESSMENT SCALE; FATIGUE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOME CARE; HOSPICE PATIENT; HOSPITAL PATIENT; HUMAN; INTERVIEW; KARNOFSKY PERFORMANCE STATUS; MALE; NAUSEA; OUTCOME ASSESSMENT; OUTPATIENT; PAIN; PATIENT MONITORING; PIPER FATIGUE SCALE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; WELLBEING;

AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HOSPICE CARE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; PALLIATIVE CARE; PLACEBO EFFECT; TERMINAL CARE; TREATMENT OUTCOME;

EID: 84855266772     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.03.026     Document Type: Article

References (32)

1. N. Vogelzang, W. Breitbart, and D. Cella Patient, caregiver, and oncologist perception of cancer-related fatigue: results of a tripart assessment survey Semin Hematol 34 1997 4 12 (Pubitemid 27319139)
2. E.B. Curtis, R. Krech, and T.D. Walsh Common symptoms in patients with advanced cancer J Palliat Care 7 1991 25 29
3. D. Irvine, L. Vincent, and J. Graydon The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiation therapy: a comparison with the fatigue experienced by healthy individuals Cancer Nurs 17 1994 367 378 (Pubitemid 24300143)
4. S. Yellen, D. Cella, and K. Webster Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system J Pain Symptom Manage 13 1997 63 74 (Pubitemid 27147321)
5. National Comprehensive Cancer Network Cancer-Related Fatigue Panel Cancer-related fatigue. NCCN practice guideline in oncology Vol. 1 2006 National Comprehensive Cancer Network Jenkintown, PA
6. O. Minton, A. Richardson, M. Sharpe, M. Hotopf, and P. Stone Drug therapy for the management of cancer-related fatigue Cochrane Database Syst Rev 1 2008 CD006704
7. W. Breitbart, B. Rosenfeld, and M. Kaim A randomized double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease Arch Intern Med 161 2001 411 420 (Pubitemid 32116559)
8. G.J. Wagner, and R. Rabkin Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial J Clin Psychiatry 61 2000 436 440 (Pubitemid 30452211)
9. N. Sarhill, D. Walsh, and K.A. Nelson Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study Am J Hosp Palliat Care 18 2001 187 192
10. E. Bruera, L. Driver, and E.A. Barnes Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report J Clin Oncol 21 2003 4439 4443 (Pubitemid 46621822)
11. J.R. Hardy, S.A. Carmont, and A. O'Shea Pilot study to determine optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer J Palliat Med 13 2010 1193 1197
12. E. Bruera, V. Valero, and L. Driver Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial J Clin Oncol 24 2006 2073 2078 (Pubitemid 46622117)
13. K.A. Auret, S. Schug, A.P. Bremner, and M. Bulsara A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer J Pain Symptom Manage 37 2009 613 621
14. A.R. Moraska, A. Sood, and S.R. Dakhil Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: north central cancer treatment group NCCTG-N05C7 Trial J Clin Oncol 28 2010 3673 3679
15. M. Rozans, A. Dreisbach, and J. Lertora Palliative uses of methylphenidate in patients with cancer: a review J Clin Oncol 20 2002 335 339 (Pubitemid 34032629)
16. M. Candy, L. Jones, and R. Williams Psychostimulants for depression Cochrane Database Syst Rev 2 2008 CD006722
17. J. Homsi, K.A. Nelson, and N. Sarhill A phase II study of methylphenidate for depression in advanced cancer Am J Hosp Palliat Care 18 2001 403 407
18. P.B. Jacobsen, and M.A. Weitzner Evaluating the relationship of fatigue to depression and anxiety in cancer patients R.K. Portenoy, E. Bruera, Issues in palliative care research 2003 Oxford University Press New York 127 149
19. V.T. Chang, S.S. Hwang, and M. Feuerman Validation of the Edmonton Symptom Assessment Scale Cancer 88 2000 2164 2171 (Pubitemid 30233220)
20. E. Bruera, N. Kuehn, M.J. Miller, P. Selmser, and K. Macmillan The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients J Palliat Care 7 1991 6 9
21. B.F. Piper, A.M. Lindsey, and M.J. Dodd The development of an instrument to measure the subjective dimension of fatigue S.G. Funk, E.M. Tornquist, M.T. Champagne, Key aspects of comfort: Management of pain, fatigue and nausea 1989 Springer Publishing Co., Inc. New York 199 208
22. K.A. Lee, G. Hicks, and G. Nino-Murcia Validity and reliability of a scale to assess fatigue Psychiatry Res 36 1991 291 298
23. A.T. Beck, C.H. Ward, and M. Mendelson An inventory for measuring depression Arch Gen Psychiatry 4 1961 561 571
24. L.S. Radloff The CES-D scale: a self-report depression scale for research in the general population Appl Psychol Meas 1 1977 385 401
25. E. Bruera, and S. Yennurajalingam Challenge of managing cancer-related fatigue J Clin Oncol 28 2010 3671 3672
26. E. Bruera, R. Fainsinger, and T. MacEachern The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report Pain 50 1992 75 77
27. E. Bruera, S. Chadwick, and C. Brennels Methylphenidate associated with narcotics for the treatment of cancer pain Cancer Treat Rep 71 1987 67 70 (Pubitemid 17003435)
28. S. Yennurajalingam, J. Palmer, and Z. Li Factors associated with response to methylphenidate in advanced cancer patients with cancer-related fatigue [abstract] J Clin Oncol 28 Suppl 2010 637s
29. K.L. Kirsh, S. Passik, and E. Holtsclaw I get tired for no reason: a single item screening for cancer-related fatigue J Pain Symptom Manage 22 2001 931 937 (Pubitemid 33111995)
30. L. Wagner, and D. Cella Cancer-related fatigue: Clinical screening, assessment, and management. ESO scientific updates: Fatigue, asthenia, exhaustion and cancer 5th ed. 2001 Elsevier Science Oxford, UK
31. D.J. Casarett, and J.H.T. Karlawish Are special ethical guidelines needed for palliative care research? J Pain Symptom Manage 20 2000 130 139
32. E.K. Wilkinson Problems of conducting research in palliative care N. Bosanquet, C. Salisbury, Providing a palliative care service: Towards an evidence base 1999 Oxford University Press New York 22 29